Shijiazhuang Yiling Pharmaceutical Co Ltd (002603.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE1000015S0
Shijiazhuang Yiling Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 6.51 bn CNY | 7.83 bn CNY |
| Gross profit | 3.03 bn CNY | 5.03 bn CNY |
| Operating income | -688.90 m CNY | 1.78 bn CNY |
| EBIT | -837.02 m CNY | 1.59 bn CNY |
| Net income | -724.52 m CNY | 1.29 bn CNY |
| Diluted EPS – continuing operations | -0.43 CNY | 0.77 CNY |
Full history since 2008, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shijiazhuang Yiling Pharmaceutical Co Ltd
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine in China and internationally. It offers dietary supplements, and healthy food and drinks; patent TCM products for respiratory health, cardiovascular disease, diabetes, mellitus, oncology, urologic disease, sleep-improving, and anti-aging; disinfection and personal protective equipment products; and TCM formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
More stocks
- Kinik Co (1560.TW)
- Jiangsu Hoperun Software Co Ltd (300339.SZ)
- Siegfried Holding AG (SFZN.SW)
- Jinneng Holding Shanxi Coal Industry Co Ltd (601001.SS)
- Odakyu Electric Railway Co Ltd (9007.T)
- Rush Street Interactive, Inc. (RSI)
- ITRON, INC. (ITRI)
- Suzhou Zelgen Biopharmaceuticals Co Ltd (688266.SS)
- ROBERT HALF INC. (RHI)
- Hess Midstream LP (HESM)
- AP Memory Technology Corp (6531.TW)
- City of London Investment Trust PLC (CTY.L)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.